ClinVar Miner

Submissions for variant NM_032380.5(GFM2):c.1758G>C (p.Arg586Ser)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV002472098 SCV002768505 uncertain significance Combined oxidative phosphorylation deficiency 39 2019-08-28 criteria provided, single submitter clinical testing A heterozygous missense variant, NM_032380.4(GFM2):c.1758G>C, has been identified in exon 18 of 21 of the GFM2 gene. The variant is predicted to result in a major amino acid change from arginine to serine at position 586 of the protein (NP_115756.2(GFM2):p.(Arg586Ser)). The arginine residue at this position has low conservation (100 vertebrates, UCSC), and is located within the Elongation factor G, domain IV functional domain. In silico predictions of pathogenicity for this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is absent in population databases (gnomAD) and has not been previously reported in clinical cases. Based on the information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.